RESUMO
Viral venereal diseases remain difficult to treat. Human papilloma virus (HPV) and herpes simplex virus (HSV) are two common viral venereal diseases. HPV infections are characterized by anogenital warts and less commonly by premalignant or malignant lesions. HSV infections classically present as grouped vesicles on an erythematous base with associated burning or pain; however, immunosuppressed patients may have atypical presentations with nodular or ulcerative lesions. This review discusses the epidemiology, diagnosis, and management of anogenital HPV and HSV infections with an emphasis on treatment modalities for the practicing dermatologist. Diagnosis of these diseases typically relies on clinical assessment, although multiple diagnostic techniques can be utilized and are recommended when diagnosis is uncertain or evaluating an individual with increased risk of malignancy. Management of HPV and HSV infections involves appropriate counseling, screening, and multiple treatment techniques. Particularly for HPV infections, a practitioner may need to use a combination of techniques to achieve the desired outcome.
Assuntos
Infecções por Herpesviridae/diagnóstico , Infecções por Papillomavirus/diagnóstico , Doenças Virais Sexualmente Transmissíveis/diagnóstico , Dermatopatias Virais/diagnóstico , Alphapapillomavirus/isolamento & purificação , Terapia Combinada/métodos , Terapia Combinada/normas , Aconselhamento/normas , Dermatologia/métodos , Dermatologia/normas , Herpesviridae/isolamento & purificação , Infecções por Herpesviridae/epidemiologia , Infecções por Herpesviridae/terapia , Infecções por Herpesviridae/transmissão , Humanos , Programas de Rastreamento/normas , Infecções por Papillomavirus/epidemiologia , Infecções por Papillomavirus/terapia , Infecções por Papillomavirus/transmissão , Guias de Prática Clínica como Assunto , Prevalência , Fatores de Risco , Doenças Virais Sexualmente Transmissíveis/epidemiologia , Doenças Virais Sexualmente Transmissíveis/terapia , Doenças Virais Sexualmente Transmissíveis/transmissão , Pele/patologia , Pele/virologia , Dermatopatias Virais/epidemiologia , Dermatopatias Virais/terapia , Dermatopatias Virais/transmissãoRESUMO
ABSTRACT CONTEXT: Various skin manifestations have been reported in coronavirus disease. It may be difficult to determine the etiology of these lesions in view of the increased frequency of handwashing during the pandemic, along with occurrences of irritant contact dermatitis and allergic contact dermatitis due to disinfectant use; usage of herbal medicine and supplements to strengthen the immune system; and urticarial or maculopapular drug eruptions due to COVID-19 treatment. The variety of associated skin manifestations seen with COVID-19 makes it challenging to identify virus-specific skin manifestations. Petechiae, purpura, acrocyanosis and necrotic and non-necrotic purpura, which can be considered as manifestations of vascular involvement on the skin, have been reported. CASE REPORT: Here, we report a case of eruptive cherry angiomas, which was thought to have developed due to COVID-19, with a papulovesicular rash on distal extremities that progressed over time to reticular purpura. CONCLUSION: The case presented had a papulovesicular rash at the onset, which evolved to retiform purpura, and eruptive cherry angiomas were observed. It should be kept in mind that dermatological signs may vary in patients with COVID-19.
Assuntos
Humanos , Masculino , Feminino , Pessoa de Meia-Idade , Púrpura/virologia , Pele/virologia , Dermatopatias Virais/virologia , Exantema/virologia , COVID-19/complicações , COVID-19/virologia , Hemangioma/virologia , Pele/efeitos dos fármacos , Pele/patologia , Resultado do Tratamento , Dermatopatias Virais/diagnóstico , Dermatopatias Virais/terapia , Teste para COVID-19 , SARS-CoV-2 , COVID-19/tratamento farmacológico , COVID-19/terapiaRESUMO
BACKGROUND: Since December 2019, the global population has been experiencing an unprecedented challenge due to Corona virus disease (COVID-19). A pandemic was declared by the World Health Organization on March 11th 2020, with an escalation of new cases worldwide. Dermatology units experienced a reorganization of regular activity, also providing clinical diagnosis and medical assistance to COVID-19-positive patients who developed cutaneous manifestations. OBJECTIVE: To evaluate the impact of the COVID-19 pandemic on Italian dermatologic clinical practice. MATERIALS & METHODS: This was a prospective online survey, consisting of a questionnaire with 35 multiple-choice questions uploaded on the website of the Italian Society of Dermatology and Venereology - SIDeMaST. RESULTS: A total of 136 dermatologists, 78 women (57%) and 58 men (43%), participated in the survey. The mean age was 58 ± 14 years. In total, 60% of participants reported an impact of the pandemic on their practice, in most cases consisting of a remarkable reduction in routine clinical activity (58%). Concern regarding possible infection was evaluated with a score ranging from 0 (no concern) to 5 (extremely concerned): the fear of becoming infected was high (≥3 in 40%), as was the fear of infecting families, colleagues or patients (≥3 points in 45%). CONCLUSION: The COVID-19 pandemic is having a strong impact on dermatology practice in Italy. The identification of critical points may help scientific societies to improve the clinical scenario and create specific strategies to overcome the emergency.
Assuntos
COVID-19/epidemiologia , Dermatologia/organização & administração , Padrões de Prática Médica , COVID-19/transmissão , Dermatologistas/psicologia , Medo , Feminino , Pesquisas sobre Atenção à Saúde , Humanos , Transmissão de Doença Infecciosa do Paciente para o Profissional , Itália/epidemiologia , Masculino , Pessoa de Meia-Idade , Pandemias , Estudos Prospectivos , Fatores de Risco , SARS-CoV-2 , Dermatopatias Virais/diagnóstico , Dermatopatias Virais/terapiaRESUMO
CONTEXT: Various skin manifestations have been reported in coronavirus disease. It may be difficult to determine the etiology of these lesions in view of the increased frequency of handwashing during the pandemic, along with occurrences of irritant contact dermatitis and allergic contact dermatitis due to disinfectant use; usage of herbal medicine and supplements to strengthen the immune system; and urticarial or maculopapular drug eruptions due to COVID-19 treatment. The variety of associated skin manifestations seen with COVID-19 makes it challenging to identify virus-specific skin manifestations. Petechiae, purpura, acrocyanosis and necrotic and non-necrotic purpura, which can be considered as manifestations of vascular involvement on the skin, have been reported. CASE REPORT: Here, we report a case of eruptive cherry angiomas, which was thought to have developed due to COVID-19, with a papulovesicular rash on distal extremities that progressed over time to reticular purpura. CONCLUSION: The case presented had a papulovesicular rash at the onset, which evolved to retiform purpura, and eruptive cherry angiomas were observed. It should be kept in mind that dermatological signs may vary in patients with COVID-19.
Assuntos
COVID-19/complicações , COVID-19/virologia , Exantema/virologia , Hemangioma/virologia , Púrpura/virologia , Dermatopatias Virais/virologia , Pele/virologia , COVID-19/terapia , Teste para COVID-19 , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , SARS-CoV-2 , Pele/efeitos dos fármacos , Pele/patologia , Dermatopatias Virais/diagnóstico , Dermatopatias Virais/terapia , Resultado do Tratamento , Tratamento Farmacológico da COVID-19RESUMO
No disponible
Assuntos
Humanos , Masculino , Pessoa de Meia-Idade , Infecções por Coronavirus/diagnóstico , Infecções por Coronavirus/virologia , Pneumonia Viral/diagnóstico , Pneumonia Viral/virologia , Pele/virologia , Dermatopatias Virais/virologia , Dermatopatias Virais/diagnóstico , Dermatopatias Virais/terapia , Eritema/tratamento farmacológico , Prednisona/administração & dosagem , Beclometasona/administração & dosagem , Infecções por Coronavirus/tratamento farmacológico , Pneumonia Viral/tratamento farmacológico , Betacoronavirus/efeitos dos fármacosAssuntos
Betacoronavirus , Técnicas de Laboratório Clínico , Infecções por Coronavirus/complicações , Pneumonia Viral/complicações , Dermatopatias Virais/diagnóstico , Dermatopatias Virais/etiologia , Dedos do Pé , COVID-19 , Teste para COVID-19 , Infecções por Coronavirus/diagnóstico , Progressão da Doença , Humanos , Pandemias , SARS-CoV-2 , Dermatopatias Virais/terapiaRESUMO
Skin manifestations of COVID-19 infections are diverse and are new to the dermatology community. We had the opportunity to examine the clinical and histopathological features of several patients who were divided into 3 groups. The first group included 8 COVID-19-positive patients who were hospitalized and quarantined at home. The second group included children and young adults who presented with chilblain erythema, erythema multiforme, and urticaria-like lesions. This group of patients was negative for the COVID-19 gene sequences by polymerase chain reaction but had a high risk of COVID-19 infection. The third group included clinically heterogeneous and challenging lesions. These patients were not subject to either polymerase chain reaction tests or serological analyses because they sought dermatological attention only for a dermatosis. The histopathological analysis of these cases showed a wide spectrum of histopathological patterns. What appears to be constant in all skin biopsies was the presence of prominent dilated blood vessels with a swollen endothelial layer, vessels engulfed with red blood cells, and perivascular infiltrates, consisting mainly of cytotoxic CD8+ lymphocytes and eosinophils. In 2 cases, there was diffuse coagulopathy in the cutaneous vascular plexus. In the early phases of the disease, there were numerous collections of Langerhans cells in the epidermis after being activated by the virus. The presence of urticarial lesions, chilblains, targetoid lesions (erythema multiforme-like lesions), exanthema, maculohemorrhagic rash, or chickenpox-like lesions associated with the histopathological features mentioned previously should cause clinical dermatologists to suspect the possibility of COVID-19 infection, especially in patients with fever and cough.
Assuntos
Infecções por Coronavirus/epidemiologia , Pneumonia Viral/epidemiologia , Síndrome Respiratória Aguda Grave/epidemiologia , Dermatopatias Virais/epidemiologia , Dermatopatias Virais/patologia , Adolescente , Fatores Etários , Biópsia por Agulha , COVID-19 , Estudos de Coortes , Comorbidade , Infecções por Coronavirus/diagnóstico , Infecções por Coronavirus/terapia , DNA Viral/análise , Feminino , Seguimentos , Humanos , Imuno-Histoquímica , Incidência , Itália/epidemiologia , Masculino , Pandemias , Pneumonia Viral/diagnóstico , Pneumonia Viral/terapia , Reação em Cadeia da Polimerase/métodos , Estudos Retrospectivos , Medição de Risco , Síndrome Respiratória Aguda Grave/diagnóstico , Índice de Gravidade de Doença , Fatores Sexuais , Dermatopatias Virais/terapia , Adulto JovemAssuntos
Infecções Assintomáticas , Teste para COVID-19 , COVID-19/diagnóstico , Portador Sadio , Dermatologistas , Papel do Médico , Dermatopatias Virais/diagnóstico , COVID-19/terapia , COVID-19/transmissão , COVID-19/virologia , Humanos , Valor Preditivo dos Testes , Prognóstico , Medição de Risco , Fatores de Risco , Dermatopatias Virais/terapia , Dermatopatias Virais/transmissão , Dermatopatias Virais/virologiaRESUMO
Since the COVID-19 infection first appeared in December 2019, patient profile of outpatient and inpatient clinics has changed. Various cutaneous findings associated with COVID-19 have been reported in the literature. The main objective of this study was to describe and analyze the profile of the consultations requested from dermatology department during the COVID pandemic. Retrospective, cohort study. In this study, we observed the dermatology consultations of the hospitalized patients over a period of 2 months, corresponding to the peak of COVID outbreak in a tertiary care hospital in Turkey. We reviewed the inpatient dermatology consult database retrospectively. Both pediatric and adult dermatology inpatient consultations were evaluated. A total of 166 inpatient dermatology consultations were requested from dermatology department during March-May, 2020. The mean age of the patients was 53.12 (1-89) years. Almost 32.5% (n = 54) of dermatology consultations were requested from the COVID wards and the COVID intensive care unit. The second most common consultations were requested from internal medicine departments (n = 46, 27.7%). The most common indications for the consultations were cutaneous infections (36%), followed by inflammatory disorders (32%), and urticaria (11%). Dermatology consultations have an essential role on the management of hospitalized patients, especially at that pandemic time. Careful dermatological examination improves diagnostic accuracy in skin disorders and skin manifestations of COVID-19 infection that provides an early diagnosis and treatment, helps to improve the quality of the patient care and management.
Assuntos
COVID-19/virologia , Dermatologia/tendências , Pacientes Internados , Encaminhamento e Consulta/tendências , Dermatopatias Virais/diagnóstico , Centros de Atenção Terciária/tendências , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , COVID-19/complicações , COVID-19/diagnóstico , COVID-19/terapia , Criança , Pré-Escolar , Bases de Dados Factuais , Diagnóstico Diferencial , Diagnóstico Precoce , Feminino , Humanos , Lactente , Masculino , Pessoa de Meia-Idade , Prognóstico , Estudos Retrospectivos , Dermatopatias Virais/terapia , Dermatopatias Virais/virologia , Turquia , Adulto JovemRESUMO
BACKGROUND: Various cutaneous manifestations have been observed in patients with COVID-19 infection. However, overall similarities in the clinical presentation of these dermatological manifestations have not yet been summarized. OBJECTIVE: This review aims to provide an overview of various cutaneous manifestations in patients with COVID-19 through three case reports and a literature review. METHODS: A literature search was conducted using PubMed, OVID, and Google search engines for original and review articles. Studies written in the English language that mentioned cutaneous symptoms and COVID-19 were included. RESULTS: Eighteen articles and three additional cases reported in this paper were included in this review. Of these studies, 6 are case series and 12 are case report studies. The most common cutaneous manifestation of COVID-19 was found to be maculopapular exanthem (morbilliform), presenting in 36.1% (26/72) patients. The other cutaneous manifestations included: a papulovesicular rash (34.7%, 25/72), urticaria (9.7%, 7/72), painful acral red purple papules (15.3%, 11/72) of patients, livedo reticularis lesions (2.8%, 2/72) and petechiae (1.4%, 1/72). Majority of lesions were localized on the trunk (66.7%, 50/72), however, 19.4% (14/72) of patients experienced cutaneous manifestations in the hands and feet. Skin lesion development occurred before the onset of respiratory symptoms or COVID-19 diagnosis in 12.5% (9/72) of the patients, and lesions spontaneously healed in all patients within 10 days. Majority of the studies reported no correlation between COVID-19 severity and skin lesions. CONCLUSION: Infection with COVID-19 may result in dermatological manifestations with various clinical presentations, which may aid in the timely diagnosis of this infection.
Assuntos
Betacoronavirus/patogenicidade , Infecções por Coronavirus/virologia , Pneumonia Viral/virologia , Dermatopatias Virais/virologia , Pele/virologia , Idoso , Antivirais/uso terapêutico , COVID-19 , Teste para COVID-19 , Técnicas de Laboratório Clínico , Infecções por Coronavirus/diagnóstico , Infecções por Coronavirus/terapia , Progressão da Doença , Diagnóstico Precoce , Feminino , Humanos , Oxigenoterapia , Pandemias , Pneumonia Viral/diagnóstico , Pneumonia Viral/terapia , Valor Preditivo dos Testes , SARS-CoV-2 , Pele/efeitos dos fármacos , Pele/patologia , Dermatopatias Virais/diagnóstico , Dermatopatias Virais/terapia , Fatores de Tempo , Resultado do TratamentoRESUMO
Extragenital cutaneous warts are benign epidermal tumors caused by human papillomaviruses (HPVs) and a frequent reason for patients to consult a dermatologist. Depending on wart type and site involved, the clinical presentation is highly varied. Given that warts represent a self-limiting condition, a wait-and-see approach may be justified. However, treatment is always indicated if the lesions become painful or give rise to psychological discomfort. Factors to be considered in this context include subjective disease burden, patient age, site affected, as well as the number and duration of lesions. Destructive treatment methods involve chemical or physical removal of diseased tissue. Nondestructive methods consist of antimitotic and antiviral agents aimed at inhibiting viral proliferation in keratinocytes. Some of the various immunotherapies available not only have localized but also systemic effects and are thus able to induce remission of warts located at any distance from the injection site. Especially patients with warts at multiple sites benefit from this form of treatment. Intralesional immunotherapy using the mumps-measles-rubella (MMR) vaccine is a particularly promising option for the treatment of recalcitrant warts in adult patients. For children, on the other hand, HPV vaccination is a novel and promising approach, even though it has not been approved for the treatment of cutaneous warts. At present, there is no universally effective treatment available. Moreover, many frequently employed therapies are currently not supported by conclusive clinical trials.
Assuntos
Dermatopatias Virais/terapia , Verrugas/terapia , Acetatos/uso terapêutico , Adulto , Antivirais/uso terapêutico , Crioterapia/métodos , Curetagem/métodos , Feminino , Fluoruracila/uso terapêutico , Formiatos/uso terapêutico , Humanos , Terapia a Laser/métodos , Masculino , Fototerapia/métodos , Ácido Salicílico/uso terapêutico , Dermatopatias Virais/patologia , Dermatopatias Virais/transmissão , Verrugas/patologia , Verrugas/transmissão , Conduta ExpectanteRESUMO
The use of immunosuppressing agents can act as a catalyst for viral reactivation, promoting systemic infection with organ involvement. Current literature remains sparse on this topic but does provide individual case reports involving single viruses. We present the case of an immunocompromised patient with skin lesions, pancreatitis, colitis and hepatitis. Work-up revealed varicella zoster virus, which likely put the patient at risk for multi-organ involvement, as well as clinical suspicion of other implicated viruses, specifically herpes simplex virus and cytomegalovirus. A high clinical index of suspicion along with biopsy guidance for viral involvement in immunocompromised patients is crucial for early diagnosis and treatment of these conditions.
Assuntos
Antivirais/uso terapêutico , Colite/virologia , Hepatite/virologia , Doenças da Boca/virologia , Pancreatite/virologia , Síndrome do Desconforto Respiratório/virologia , Dermatopatias Virais/patologia , Ativação Viral/imunologia , Infecções por Citomegalovirus/imunologia , Evolução Fatal , Feminino , Herpes Simples/imunologia , Herpes Zoster/imunologia , Humanos , Hospedeiro Imunocomprometido , Pessoa de Meia-Idade , Mucosa Bucal/virologia , Multimorbidade , Conforto do Paciente , Síndrome do Desconforto Respiratório/fisiopatologia , Simplexvirus/imunologia , Dermatopatias Virais/terapia , Latência ViralRESUMO
BACKGROUND: Human polyomaviruses (HPyVs) are small, nonenveloped, double-stranded DNA viruses that express tumour antigen proteins. Fourteen species of polyomaviruses have been discovered in humans, and since the 2008 discovery of the first cutaneous polyomavirus - Merkel cell polyomavirus (MCPyV) - six more species have been detected in the skin: trichodysplasia spinulosa-associated polyomavirus (TSPyV), HPyV6, HPyV7, HPyV9, HPyV10 and HPyV13. Of these cutaneous species, only MCPyV, TSPyV, HPyV6 and HPyV7 have been definitively associated with diseases of the skin, most commonly in immunocompromised individuals. MCPyV is a predominant aetiology in Merkel cell carcinomas. TSPyV is one of the aetiological factors of trichodysplasia spinulosa. HPyV6 and HPyV7 have been recently linked to pruritic skin eruptions. The roles of HPyV9, HPyV10 and HPyV13 in pathogenesis, if any, are still unknown, but their molecular features have provided some insight into their functional biology. RESULTS: In this review, we summarize the known molecular mechanisms, clinical presentation and targeted therapies of each of the eight cutaneous HPyVs. CONCLUSIONS: We hope that heightened awareness and clinical recognition of HPyVs will lead to increased reports of HPyV-associated diseases and, consequently, a more robust understanding of how to diagnose and treat these conditions.
Assuntos
Doenças Transmissíveis Emergentes/virologia , Infecções por Polyomavirus/virologia , Polyomavirus/fisiologia , Dermatopatias Virais/virologia , Infecções Tumorais por Vírus/virologia , Carcinogênese , Doenças Transmissíveis Emergentes/terapia , Humanos , Hospedeiro Imunocomprometido , Polyomavirus/genética , Infecções por Polyomavirus/terapia , Dermatopatias Virais/terapia , Infecções Tumorais por Vírus/terapiaRESUMO
BACKGROUND: Cutaneous warts have a cure rate after therapy of no more than approximately 50%. Recently, we developed and validated a standard assessment tool for warts (Cutaneous WARTS diagnostic tool, CWARTS) based on phenotypical characteristics. OBJECTIVES: To assess whether patient and morphological wart characteristics predict the human papillomavirus (HPV) type in a specific wart and whether these characteristics as well as the HPV type predict a favourable treatment response. METHODS: Photographs were used to score nine morphological wart characteristics using the newly developed CWARTS tool. Genotyping of 23 wart-associated HPV types was performed using the hyperkeratotic skin lesion-polymerase chain reaction/multiplex genotyping assay. The results were correlated with a favourable response to treatment with monochloroacetic acid, cryotherapy or a combination of cryotherapy and salicylic acid. Odds ratios were calculated using logistic regression in a generalized estimating equations model. RESULTS: Black dots (capillary thrombosis) strongly predicted the presence of any HPV type in a wart. From all characteristics tested, the HPV type most strongly predicted the treatment response when the warts were treated with monochloroacetic acid or a combination of cryotherapy and salicylic acid with a significantly decreased treatment response if the warts contained HPVs of the alpha genus (HPV2, HPV27 or HPV57). When cryotherapy alone was used for common warts, HPV type did not play a role, but cryotherapy was less effective in the presence of callus and when the wart was located deeper in the skin. CONCLUSIONS: Morphological characteristics of the warts and the HPV genotype influence treatment outcome and thus potentially influence future treatment decisions for common and plantar warts.
Assuntos
Papillomaviridae/genética , Dermatopatias Virais/genética , Verrugas/genética , Acetatos/uso terapêutico , Adolescente , Adulto , Idoso , Antivirais/uso terapêutico , Criança , Pré-Escolar , Crioterapia/métodos , Feminino , Dermatoses do Pé/genética , Dermatoses do Pé/patologia , Genótipo , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Ácido Salicílico/uso terapêutico , Dermatopatias Virais/patologia , Dermatopatias Virais/terapia , Resultado do Tratamento , Verrugas/patologia , Verrugas/terapia , Adulto JovemRESUMO
The second part of this publication deals with varicella zoster virus (VZV) and presents an overview of new, rare, and atypical clinical manifestations, including photolocalized varicella, hemorrhagic bullae during varicella, the implication of VZV in immunoglobulin A vasculitis, VZV-related alopecia, ulcerative varicella skin lesions, childhood herpes zoster (HZ), prolonged prodromal pains, recurrent HZ, VZV implication in burning mouth syndrome, verruciform VZV lesions, the significance of satellite lesions during HZ, and late HZ complications, either neurological or internal. Furthermore, certain associations between the occurrence of HZ and subsequent internal pathologies, as well as risk factors for HZ and new developments in vaccination against HZ will be addressed.
Assuntos
Antivirais/administração & dosagem , Herpes Zoster/diagnóstico , Herpes Zoster/terapia , Herpesvirus Humano 3/isolamento & purificação , Dermatopatias Virais/diagnóstico , Dermatopatias Virais/terapia , Vacinas Virais/administração & dosagem , Medicina Baseada em Evidências , Herpes Zoster/virologia , Humanos , Dermatopatias Virais/virologia , Resultado do TratamentoRESUMO
BACKGROUND: Canine pigmented viral plaque (PVP) is an uncommon skin disease, associated with papillomavirus infection. Lesions are usually small (<1 cm diameter), pigmented macules to plaques on the ventral abdomen and medial thigh. ANIMALS: An 8-year-old male, neutered golden retriever dog presented with numerous dark plaques forming cohesive plaques on the ventrum extending down the medial aspect of both hind legs. The plaques were associated with significant pruritus. RESULTS: Histology confirmed a diagnosis of PVP and PCR amplified Canis familiaris papillomavirus 4 from a formalin fixed plaque sample. The PVPs were completely resolved by two courses of CO2 laser treatment. There was very minimal postoperative discomfort and no relapse or new lesion development within a 12 months follow-up period. CONCLUSIONS AND CLINICAL IMPORTANCE: Extensive PVPs have not previously been described in a golden retriever dog or previously reported to cause pruritus in dogs. Due to the large skin area involved, surgical excision was not feasible in this case. However, two rounds of treatment using laser were completely curative for both focal pedunculated and plaque-like PVP lesions. Additionally, compared to surgical excision, laser treatment is expected to result in less postoperative discomfort, reduced surgery time and fewer postoperative infections. This is the first report of successful treatment of canine PVPs using a CO2 laser. The success of this treatment in this case suggests that laser provides an excellent treatment option for extensive PVPs in dogs.
Assuntos
Doenças do Cão/terapia , Terapia a Laser/veterinária , Lasers de Gás , Dermatopatias Virais/veterinária , Animais , Anti-Infecciosos Locais/uso terapêutico , Cães , Masculino , Sulfadiazina de Prata/uso terapêutico , Dermatopatias Virais/patologia , Dermatopatias Virais/terapiaRESUMO
In the vast world of skin diseases, viral skin disorders account for a significant percentage. Most viral skin diseases present with an exanthem (skin rash) and, oftentimes, an accompanying enanthem (lesions involving the mucosal membrane). In this article, the various viral skin diseases are explored, including viral childhood exanthems (measles, rubella, erythema infectiosum, and roseola), herpes viruses (herpes simplex virus, varicella zoster virus, Kaposi sarcoma herpes virus, viral zoonotic infections [orf, monkeypox, ebola, smallpox]), and several other viral skin diseases, such as human papilloma virus, hand, foot, and mouth disease, molluscum contagiosum, and Gianotti-Crosti syndrome.